| S7072 |
NMDA (N-Methyl-D-aspartic acid)
|
NMDA (N-Methyl-D-aspartic acid) is a specific agonist for the NMDA receptor, mimicking the action of glutamate, the neurotransmitter which normally acts at that receptor. Phase 4.
|
-
Theranostics, 2025, 15(14):6901-6918
-
Sci Rep, 2025, 15(1):17364
-
J Neurotrauma, 2025, 10.1177/08977151251374286
|
|
| S3624 |
Quinolinic acid
|
Quinolinic acid (pyridine-2,3-dicarboxylic acid, QUIN), a neuroactive metabolite of the kynurenine pathway, is an agonist of N-methyl-D-aspartate (NMDA) receptor.
|
|
|
| S6907 |
Rapastinel (GLYX-13)
|
Rapastinel (GLYX-13, BV-102, TPPT-amide) is a partial agonist of N-methyl-D-aspartate receptor (NMDAR) that targets a glycine site, and it has long-lasting antidepressant effects.
|
|
|
| S6224 |
(R)-Serine
|
(R)-Serine is the R-enantiomer of serine, which is used in the biosynthesis of proteins. This compound acts as obligatory coagonist at the glycine site associated with the N-methyl-D-aspartate subtype of glutamate receptors (NMDAR) and has a cardinal modulatory role in major NMDAR-dependent processes including NMDAR-mediated neurotransmission, neurotoxicity, synaptic plasticity, and cell migration.
|
|
|
| S3203 |
D-Alanine
|
D-Alanine (Ala, (R)-Alanine, Ba 2776, D-α-Alanine, NSC 158286) is an endogenous co-agonist at the glycine site of the N-methyl-d-aspartate (NMDA) receptor.
|
|
|
| S4702 |
Sarcosine
|
Sarcosine (N-methylglycine, Sarcosinic acid, Methylaminoacetic acid, Methylglycine) is a competitive inhibitor of the type I glycine transporter (GlyT1) and an NMDAR co-agonist.
|
|
|